Elizabeth C. Squiers
Corporate Officer/Principal bij Quark Pharmaceuticals, Inc.
Profiel
Elizabeth C.
Squiers is currently the Vice President-Pharmacovigilance at Quark Pharmaceuticals, Inc. She previously worked as the Director-Transplantation Program at The State University of New York, Vice President at SangStat Medical Corp., Genzyme Corp., and Thios Pharmaceuticals, Inc., Chief Medical Officer at Y's Therapeutics, Inc., and Assistant Professor at Sidney Kimmel Medical College.
She also worked as an Independent Consultant at Pacific Biodevelopment, LLC.
Dr. Squiers received her undergraduate degree from The Pennsylvania State University and her doctorate from Sidney Kimmel Medical College.
Actieve functies van Elizabeth C. Squiers
| Bedrijven | Functie | Begin |
|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Corporate Officer/Principal | 27-09-2010 |
Eerdere bekende functies van Elizabeth C. Squiers
| Bedrijven | Functie | Einde |
|---|---|---|
| SangStat Medical Corp. | Corporate Officer/Principal | - |
| Pacific Biodevelopment, LLC | Corporate Officer/Principal | - |
| The State University of New York | Corporate Officer/Principal | - |
| Sidney Kimmel Medical College | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Opleiding van Elizabeth C. Squiers
| The Pennsylvania State University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
| SangStat Medical Corp. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Thios Pharmaceuticals, Inc.
 Thios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thios Pharmaceuticals, Inc. was engaged in providing researches therapies. The therapies provided by the company target sulfation pathways, which could lead to potential for treatments for inflammation, cancer and other diseases. Thios Pharmaceuticals was located in Oakland, CA. | Health Technology |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
Y's Therapeutics, Inc.
 Y's Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Y's Therapeutics, Inc. manufactures biopharmaceuticals. | Health Technology |
| Pacific Biodevelopment, LLC |
